Question 1

Does NewEdge Wealth own TCRX stock?

Accepted Answer

Yes. As of its Q2 2026 13F, NewEdge Wealth holds 91,463 shares of TCRX (Tscan Therapeutics), worth $89,643.

Question 2

How many shares of TCRX does NewEdge Wealth own?

Accepted Answer

As of its Q2 2026 13F, NewEdge Wealth holds 91,463 shares of TCRX (Tscan Therapeutics).

Question 3

What is NewEdge Wealth's TCRX position worth?

Accepted Answer

As of its Q2 2026 13F, NewEdge Wealth's TCRX position is worth $89,643.

Question 4

When did NewEdge Wealth first buy TCRX?

Accepted Answer

NewEdge Wealth first reported TCRX in its Q4 2022 13F and has listed it in 15 quarterly 13F filings.

Quarter	Action	Shares	Change	Value	Weight	Price
2026-Q2 Latest	Unchanged	91,463	0.0%	$89,643	0.0%	$0.98
2026-Q1	Unchanged	91,463	0.0%	$92,378	0.0%	$1.03
2025-Q4	Unchanged	91,463	0.0%	$91,463	0.0%	$1.03
2025-Q3	Unchanged	91,463	0.0%	$103,811	0.0%	$1.74
2025-Q2	Unchanged	91,463	0.0%	$150,914	0.0%	$1.40
2025-Q1	Unchanged	91,463	0.0%	$126,219	0.0%	$1.35
2024-Q4	Unchanged	91,463	0.0%	$278,048	0.0%	$3.00
2024-Q3	Unchanged	91,463	0.0%	$455,486	0.0%	$5.04